Tomoyuki Fujisawa Selected Research

Lung Neoplasms (Lung Cancer)

1/2024	Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapy.
1/2022	Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis.
1/2022	Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.
11/2020	Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' View.
11/2019	Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer.
1/2019	Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting.
12/2018	An Acquired Epidermal Growth Factor Receptor T790M Mutation after the Addition of Bevacizumab to Preceding Erlotinib Monotherapy in a Lung Cancer Patient with Leptomeningeal Metastases.
9/2017	Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated with Erlotinib and Oral Fluoropyrimidine.
1/2016	Continuation maintenance therapy with S-1 in chemotherapy-naïve patients with advanced squamous cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomoyuki Fujisawa Research Topics

Disease

29	Idiopathic Pulmonary Fibrosis 02/2024 - 09/2013
21	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2024 - 07/2003
19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 12/2015
18	Asthma (Bronchial Asthma) 01/2023 - 03/2008
16	Neoplasms (Cancer) 04/2024 - 06/2012
12	Disease Progression 02/2024 - 01/2015
11	Chronic Obstructive Pulmonary Disease (COPD) 05/2022 - 11/2009
10	Inflammation (Inflammations) 01/2023 - 08/2008
9	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2016
9	Dermatomyositis (Dermatopolymyositis) 12/2023 - 01/2015
7	Idiopathic Interstitial Pneumonias 01/2022 - 05/2008
6	Adenocarcinoma of Lung 01/2022 - 01/2017
6	Infections 02/2021 - 01/2005
5	Pneumonia (Pneumonitis) 01/2023 - 09/2011
5	Sarcoidosis (Schaumann Disease) 07/2022 - 01/2005
5	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 06/2008
5	Nausea 01/2019 - 12/2015
4	Death (Near-Death Experience) 10/2022 - 11/2020
4	Fibrosis (Cirrhosis) 01/2021 - 12/2012
4	Vomiting 01/2019 - 12/2015
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2024 - 01/2018
3	COVID-19 12/2023 - 01/2022
3	Rheumatoid Arthritis 01/2023 - 01/2015
3	Connective Tissue Diseases (Connective Tissue Disease) 01/2022 - 10/2010
3	Pneumothorax 01/2021 - 01/2020
3	Vascular Diseases (Vascular Disease) 01/2016 - 06/2009
2	Dyspnea (Shortness of Breath) 10/2022 - 01/2019
2	Hypoxia (Hypoxemia) 08/2022 - 06/2008
2	Body Weight (Weight, Body) 02/2022 - 12/2021
2	Obesity 01/2022 - 01/2019
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2022 - 06/2015
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2021
2	Melanoma (Melanoma, Malignant) 04/2021 - 12/2016
2	Myositis (Idiopathic Inflammatory Myopathies) 04/2021 - 12/2016
2	Neutropenia 01/2021 - 01/2019
2	Bronchiectasis 01/2018 - 01/2014

Drug/Important Bio-Agent (IBA)

12	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021 - 04/2012
10	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 08/2008
8	Biomarkers (Surrogate Marker)IBA 11/2021 - 09/2014
8	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 12/2015
7	Proteins (Proteins, Gene)FDA Link 02/2024 - 06/2012
7	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2019
6	CollagenIBA 02/2024 - 06/2009
6	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 01/2014
5	CytokinesIBA 12/2023 - 01/2014
5	AutoantibodiesIBA 01/2022 - 12/2016
5	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 04/2021 - 01/2015
5	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2016
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2017
4	AntibodiesIBA 02/2024 - 01/2015
4	Bleomycin (Blenoxane)FDA LinkGeneric 02/2024 - 01/2018
4	Oxygen (Dioxygen)IBA 11/2022 - 03/2017
4	NivolumabIBA 02/2022 - 01/2019
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2015
4	pirfenidoneIBA 07/2021 - 01/2014
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 07/2003
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 05/2008
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 01/2017
4	Mannose ReceptorIBA 02/2020 - 01/2018
4	AntiemeticsIBA 01/2019 - 12/2015
3	LigandsIBA 02/2022 - 06/2012
3	Peroxidase (Myeloperoxidase)IBA 01/2021 - 05/2008
3	Phenobarbital (Luminal)FDA Link 01/2019 - 12/2018
3	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 09/2013
3	Budesonide (Pulmicort)FDA LinkGeneric 01/2019 - 02/2014
3	Formoterol Fumarate (Oxis)FDA Link 01/2019 - 02/2014
3	Interleukin-17 (Interleukin 17)IBA 10/2018 - 01/2014
2	indium-bleomycinIBA 02/2024 - 08/2022
2	Docetaxel (Taxotere)FDA Link 01/2024 - 06/2018
2	VaccinesIBA 12/2023 - 11/2015
2	atezolizumabIBA 07/2023 - 01/2022
2	Indicators and Reagents (Reagents)IBA 01/2023 - 08/2018
2	Opioid Analgesics (Opioids)IBA 10/2022 - 01/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 07/2022 - 01/2022
2	Bronchodilator Agents (Bronchodilators)IBA 05/2022 - 01/2015
2	Serum AlbuminIBA 02/2022 - 12/2021
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2017
2	LipidsIBA 01/2022 - 01/2005
2	PlatinumIBA 12/2021 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2021 - 06/2015
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 01/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 06/2018
2	Angiopoietin-1IBA 01/2021 - 01/2016
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 11/2020 - 10/2010
2	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2019 - 10/2016
2	Messenger RNA (mRNA)IBA 10/2018 - 03/2008
2	Aprepitant (Emend)FDA Link 09/2018 - 12/2015
2	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 09/2018 - 07/2016
2	Pemetrexed (MTA)FDA Link 06/2018 - 05/2016
2	Fluticasone (Cutivate)FDA LinkGeneric 01/2018 - 02/2014
2	AntigensIBA 01/2018 - 01/2005
2	Salmeterol Xinafoate (Serevent)FDA Link 01/2018 - 02/2014
2	Polymyxin B (Aerosporin)FDA LinkGeneric 02/2015 - 05/2008
2	Therapeutic UsesIBA 01/2015 - 05/2008

Therapy/Procedure

41	Therapeutics 02/2024 - 06/2009
11	Drug Therapy (Chemotherapy) 01/2022 - 12/2015
4	Palliative Care (Palliative Therapy) 01/2023 - 11/2020
2	Cannula 11/2022 - 01/2020
2	Artificial Respiration (Mechanical Ventilation) 04/2022 - 06/2008
2	Aftercare (After-Treatment) 01/2022 - 06/2015